Robin Kramer - 10 Feb 2022 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Chief Accounting Officer
Signature
/s/ Wendell Taylor, attorney-in-fact for Robin Kramer
Issuer symbol
BIIB
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 15:24:04 UTC
Previous filing
21 Jan 2022
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIIB Common Stock 1,354 10 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Award $0 +2,500 $0.000000 2,500 10 Feb 2022 Common Stock 2,500 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.